IntelliDx
Founded Year
2000Stage
Series D | DeadTotal Raised
$39.9MLast Raised
$21.5MLoading...
Loading...
IntelliDx Patents
IntelliDx has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
5/23/2006 | 1/10/2012 | Blood tests, Analytical chemistry, Immunologic tests, Diabetes, Chromatography | Grant |
Application Date | 5/23/2006 |
|---|---|
Grant Date | 1/10/2012 |
Title | |
Related Topics | Blood tests, Analytical chemistry, Immunologic tests, Diabetes, Chromatography |
Status | Grant |
IntelliDx Frequently Asked Questions (FAQ)
When was IntelliDx founded?
IntelliDx was founded in 2000.
Where is IntelliDx's headquarters?
IntelliDx's headquarters is located at 3235 Kifer Road, Santa Clara.
What is IntelliDx's latest funding round?
IntelliDx's latest funding round is Series D.
How much did IntelliDx raise?
IntelliDx raised a total of $39.9M.
Who are the investors of IntelliDx?
Investors of IntelliDx include Infinity Fund, Ascend Technology Ventures, Giza Venture Capital, 3i Group, Aurum Ventures and 9 more.
Who are IntelliDx's competitors?
Competitors of IntelliDx include OptiScan Biomedical, CardioMems, Sensible Medical Innovations, GlySure, Medingo and 7 more.
Loading...
Compare IntelliDx to Competitors
OptiScan Biomedical has developed a monitoring platform for use in hospital intensive care units (ICU) to support clinicians in detecting changes more rapidly in critically ill patients, enabling more timely intervention. The OptiScanner platform is presently focused on delivering automated bedside glucose monitoring to support clinicians' reach and maintain the right level of glucose control.
Arkal Medical is developing a continuous blood glucose sensor for diabetes.
GlySure has developed a continuous glucose monitoring system using an intravascular, optical fluorescence-based sensor to support clinical implementation of Tight Glycemic Control and Intensive Insulin Therapy. The company has demonstrated through ICU testing highly accurate sensors, which can provide continuous glucose readings throughout the length of ICU stay.
technology for real-time monitoring of the metabolic state of the patient and as a endpoint of resuscitationn nCritisense's first generation product - the "CritiView" is an patient monitoring system providing real-time continuous information via four physiological parameters, sensed at the tissue level, reflecting the systemic metabolic state. nCritiView is the only device providing continuous, real-time multi-parametric physiological data at the tissue and cellular level, by monitoring the mitochondrial function and the microcirculatory blood flow and oxygen saturation.n
Solianis is a Swiss medical device company developing products for physiological monitoring
Sotera Wireless is a medical device company that focuses on the development of vital signs monitoring technology. The company's main product, the ViSi Mobile System, is a comprehensive platform designed to continuously monitor patients' vital signs such as heart rate, blood pressure, respiration rate, and skin temperature, among others. This system is primarily used in the healthcare sector, particularly in hospitals and other medical facilities. Sotera Wireless was formerly known as Triage Wireless. It was founded in 2004 and is based in San Diego, California.
Loading...